T. Rowe Price Associates’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,067
| Closed | -$20K | – | 3013 |
|
|
2021
Q4 | $20K | Hold |
1,067
| – | – | ﹤0.01% | 2957 |
|
|
2021
Q3 | $27K | Sell |
1,067
-1,158
| -52% | -$29.3K | ﹤0.01% | 2921 |
|
|
2021
Q2 | $141K | Buy |
2,225
+423
| +23% | +$26.8K | ﹤0.01% | 2783 |
|
|
2021
Q1 | $222K | Buy |
+1,802
| New | +$222K | ﹤0.01% | 2654 |
|
|
2020
Q4 | – | Sell |
-143
| Closed | -$17K | – | 2713 |
|
|
2020
Q3 | $17K | Buy |
+143
| New | +$17K | ﹤0.01% | 2579 |
|
|
2020
Q1 | – | Sell |
-7,175
| Closed | -$2.4M | – | 2562 |
|
|
2019
Q4 | $2.4M | Sell |
7,175
-372
| -5% | -$124K | ﹤0.01% | 1552 |
|
|
2019
Q3 | $2.43M | Sell |
7,547
-748
| -9% | -$241K | ﹤0.01% | 1526 |
|
|
2019
Q2 | $3.58M | Sell |
8,295
-30
| -0.4% | -$12.9K | ﹤0.01% | 1439 |
|
|
2019
Q1 | $4.71M | Buy |
8,325
+8
| +0.1% | +$4.52K | ﹤0.01% | 1410 |
|
|
2018
Q4 | $2.47M | Sell |
8,317
-2
| -0% | -$593 | ﹤0.01% | 1511 |
|
|
2018
Q3 | $5.9M | Buy |
+8,319
| New | +$5.9M | ﹤0.01% | 1439 |
|